Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Genentech identifies novel MEK inhibitors

March 2, 2010

AstraZeneca discloses novel FGFR inhibitors

March 2, 2010

Virginia G. Piper Cancer Center and TGen begin phase I trial of Pharmacyclics' PCI-32765 in cancer

March 1, 2010

FDA issues refuse to file letter to Adventrx on vinorelbine NDA

March 1, 2010

Novel dual PI3K alpha and mTOR inhibitors described by S*BIO

March 1, 2010

Merck KGaA identifies novel PDK1 inhibitors

March 1, 2010

Sunesis poised to begin phase III voreloxin trial in AML

Feb. 26, 2010

EMA approves OncoGenex's development plan for OGX-011

Feb. 26, 2010

Genta initiates once-weekly treatment schedule for tesetaxel

Feb. 26, 2010

Roche reports on phase III trial of Avastin in ovarian cancer

Feb. 26, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...